Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28968

1.

Quantitative urinary proteomics using stable isotope labelling by peptide dimethylation in patients with prostate cancer.

Li C, Zang T, Wrobel K, Huang JT, Nabi G.

Anal Bioanal Chem. 2015 Feb 28. [Epub ahead of print]

PMID:
25724369
[PubMed - as supplied by publisher]
2.

Risk of ischemic stroke after androgen deprivation therapy for prostate cancer in the Chinese population living in Hong Kong.

Teoh JY, Chiu PK, Chan SY, Poon DM, Cheung HY, Hou SS, Ng CF.

Jpn J Clin Oncol. 2015 Feb 26. pii: hyv025. [Epub ahead of print]

PMID:
25724216
[PubMed - as supplied by publisher]
3.

Serum prostate-specific antigen levels in men with prediabetes: A cross-sectional study.

Sun A, Liu R, Sun G.

Scand J Clin Lab Invest. 2015 Feb 27:1-9. [Epub ahead of print]

PMID:
25723617
[PubMed - as supplied by publisher]
4.

Capping Agent-Free Gold Nanostars Show Greatly Increased Versatility And Sensitivity For Biosensing.

Jana D, Matti C, He J, Sagle LB.

Anal Chem. 2015 Feb 27. [Epub ahead of print]

PMID:
25723296
[PubMed - as supplied by publisher]
5.

Preclinical Evaluation of 86Y-Labeled Inhibitors of Prostate-Specific Membrane Antigen for Dosimetry Estimates.

Banerjee SR, Foss CA, Pullambhatla M, Wang Y, Srinivasan S, Hobbs R, Baidoo KE, Brechbiel MW, Nimmagadda S, Mease RC, Sgouros G, Pomper MG.

J Nucl Med. 2015 Feb 26. pii: jnumed.114.149062. [Epub ahead of print]

PMID:
25722448
[PubMed - as supplied by publisher]
6.

Silver nanoprism etching-based plasmonic ELISA for the high sensitive detection of prostate-specific antigen.

Liang J, Yao C, Li X, Wu Z, Huang C, Fu Q, Lan C, Cao D, Tang Y.

Biosens Bioelectron. 2015 Feb 17;69C:128-134. doi: 10.1016/j.bios.2015.02.026. [Epub ahead of print]

PMID:
25721976
[PubMed - as supplied by publisher]
7.

Stereotactic body radiation therapy salvage reirradiation of radiorecurrent prostatic carcinoma relapsed in the prostatic bed.

Arcangeli S, Gambardella P, Agolli L, Monaco A, Dognini J, Regine G, Donato V.

Tumori. 2015 Feb 26;0(0):0. doi: 10.5301/tj.5000251. [Epub ahead of print]

PMID:
25721678
[PubMed - as supplied by publisher]
8.

Comparative investigation on clinical outcomes of robot-assisted radical prostatectomy between experienced open prostatic surgeons and novice open surgeons in a laparoscopically naïve center with a limited caseload.

Sumitomo M, Kanao K, Kato Y, Yoshizawa T, Watanabe M, Zennami K, Nakamura K.

Int J Urol. 2015 Feb 26. doi: 10.1111/iju.12711. [Epub ahead of print]

PMID:
25721437
[PubMed - as supplied by publisher]
9.

A Randomised Phase II Trial Comparing Docetaxel Plus Prednisone with Docetaxel Plus Prednisone Plus Low-Dose Cyclophosphamide in Castration-Resistant Prostate Cancer.

Porsch M, Ulrich M, Wendler JJ, Liehr UB, Reiher F, Janitzky A, Baumunk D, Schindele D, Seseke F, Lux A, Schostak M.

Chemotherapy. 2015 Feb 26;60(2):129-134. [Epub ahead of print]

PMID:
25721356
[PubMed - as supplied by publisher]
10.

Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue.

Stephan C, Jung M, Rabenhorst S, Kilic E, Jung K.

Clin Chem Lab Med. 2015 Jan 10. pii: /j/cclm.ahead-of-print/cclm-2014-1000/cclm-2014-1000.xml. doi: 10.1515/cclm-2014-1000. [Epub ahead of print]

PMID:
25720086
[PubMed - as supplied by publisher]
11.

[Evaluation of prostate cancer progression].

Mocarska A, Czarnocki K, Starosławska E, Janczarek M, Zelazowska-Cieslińska I, Losicki M, Burdan F.

Pol Merkur Lekarski. 2014 Dec;37(222):356-64. Polish.

PMID:
25715578
[PubMed - in process]
12.

Advances in imaging modalities in prostate cancer.

Bouchelouche K, Turkbey B, Choyke PL.

Curr Opin Oncol. 2015 Feb 19. [Epub ahead of print]

PMID:
25715326
[PubMed - as supplied by publisher]
13.

Prostate cancer screening in Primary Health Care: the current state of affairs.

Ranasinghe WK, Kim SP, Papa NP, Sengupta S, Frydenberg M, Bolton D, Pond D, Ried K, Marshall MJ, Persad R, Lawrentschuk N.

Springerplus. 2015 Feb 13;4:78. doi: 10.1186/s40064-015-0819-8. eCollection 2015.

PMID:
25713765
[PubMed]
Free PMC Article
14.

A comparison of bladder neck preservation and bladder neck reconstruction for urinary incontinence after radical retro pubic prostatectomy.

Izadpanahi MH, Honarmand R, Khorrami MH, Najarzadegan MR, Sichani MM, Alizadeh F.

J Res Med Sci. 2014 Dec;19(12):1140-4.

PMID:
25709654
[PubMed]
Free PMC Article
15.

[Tumour markers in chronic kidney disease.]

Mercadal L.

Nephrol Ther. 2015 Feb 20. pii: S1769-7255(15)00020-6. doi: 10.1016/j.nephro.2015.01.004. [Epub ahead of print] French.

PMID:
25709104
[PubMed - as supplied by publisher]
16.

Population-based analysis of salvage radical prostatectomy with examination of factors associated with adverse perioperative outcomes.

Pearce SM, Richards KA, Patel SG, Pariser JJ, Eggener SE.

Urol Oncol. 2015 Feb 20. pii: S1078-1439(15)00050-2. doi: 10.1016/j.urolonc.2015.01.016. [Epub ahead of print]

PMID:
25708953
[PubMed - as supplied by publisher]
17.

Comparison of Prostate Volume Measured by Endorectal Coil MRI to Prostate Specimen Volume and Mass After Radical Prostatectomy.

Mazaheri Y, Goldman DA, Di Paolo PL, Akin O, Hricak H.

Acad Radiol. 2015 Feb 21. pii: S1076-6332(15)00015-X. doi: 10.1016/j.acra.2015.01.003. [Epub ahead of print]

PMID:
25708867
[PubMed - as supplied by publisher]
18.

Exploring the Clinical Benefit of Docetaxel or Enzalutamide After Disease Progression During Abiraterone Acetate and Prednisone Treatment in Men With Metastatic Castration-Resistant Prostate Cancer.

Zhang T, Dhawan MS, Healy P, George DJ, Harrison MR, Oldan J, Chin B, Armstrong AJ.

Clin Genitourin Cancer. 2015 Jan 24. pii: S1558-7673(15)00006-3. doi: 10.1016/j.clgc.2015.01.004. [Epub ahead of print]

PMID:
25708161
[PubMed - as supplied by publisher]
19.

[Serum p2PSA derivative indexes in prostate cancer: an update].

Liu Y, Xu Y.

Zhonghua Nan Ke Xue. 2015 Jan;21(1):74-7. Chinese.

PMID:
25707145
[PubMed - in process]
20.

Reoperation after Holmium Laser Enucleation of the Prostate for Management of Benign Prostate Hyperplasia: Assessment of Risk Factors with Time to Event Analysis.

Elkoushy MA, Elshal AM, Elhilali MM.

J Endourol. 2015 Feb 23. [Epub ahead of print]

PMID:
25705817
[PubMed - as supplied by publisher]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk